BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Aditum Bio announces the appointment of Stephen Kanes, M.D. Ph.D., as Chief Executive Officer of Ancora Bio

  Aditum Bio, the biotech investment firm co-founded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman, today announced the appointment of Stephen Kanes, M.D., Ph.D., as CEO of Ancora Bio.

  November 8, 2021

   · 

  3 min read
• BioNova Announces MycoFutures North Atlantic as the Winner of the Eleventh Annual BioInnovation Challenge (BIC) at BioPort 2021

  MycoFutures North Atlantic from Newfoundland was named the winner of BioNova’s Eleventh annual BioInnovation Challenge (BIC) business pitch competition at BioPort 2021.

  November 8, 2021

   · 

  2 min read
• Business

  Ring Therapeutics Strengthens Leadership Team with Three Executive Appointments

  Ring Therapeutics today announced the extension of its leadership team with the appointments of Yong S. Chang, Ph.D., as Chief Scientific Officer, John Huynh, Ph.D., as Senior Vice President of Technical Operations, and Kevin B. Johnson, Ph.D., MBA, as Chief Regulatory Officer.

  November 8, 2021

   · 

  4 min read
• Business

  Impel NeuroPharma to Report Third Quarter 2021 Financial Results on Monday, November 15, 2021

  Impel NeuroPharma, Inc. (NASDAQ: IMPL), today announced that management will host a live webcast on Monday, November 15, 2021 at 8:30 a.m. ET to report its third quarter 2021 financial results and provide a business update.

  November 8, 2021

   · 

  1 min read
• Biotech Bay

  RAPT Therapeutics to Participate in Upcoming Investor Conferences

  RAPT Therapeutics, Inc. today announced that Brian Wong, M.D., Ph.D., President and CEO, will present at the following investor conferences in November:  Stifel 2021 Virtual Healthcare Conference

  November 8, 2021

   · 

  1 min read
• Press Releases

  Sana Biotechnology Reports Third Quarter 2021 Financial Results and Business Updates

  Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on creating and delivering engineered cells as medicines, today reported financial results and business highlights for the third quarter of 2021.

  November 8, 2021

   · 

  16 min read
• Biotech Bay

  Iovance Biotherapeutics to Present at Upcoming Conferences in November 2021

  Iovance Biotherapeutics, Inc., a late-stage biotechnology company developing novel T cell-based cancer immunotherapies, announced that senior leadership plans to present at the following conferences in November.

  November 8, 2021

   · 

  5 min read
• Business

  Nevro Reports Third Quarter 2021 Financial Results and Provides Fourth Quarter Guidance

  Nevro Corp., a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, reported its financial results for the third quarter ended September 30, 2021 and provided fourth quarter of 2021 guidance.

  November 8, 2021

   · 

  16 min read
• Biotech Bay

  Kodiak Sciences to Present at Upcoming Conferences - Nov 08, 2021

  Kodiak Sciences Inc. announced that management will present at the following upcoming virtual investor conferences.

  November 8, 2021

   · 

  2 min read
• Horizon Therapeutics plc to Participate in Upcoming Investor Conferences - Nov 08, 2021

  Horizon Therapeutics plc announced that the Company will participate in the following upcoming conferences.

  November 8, 2021

   · 

  1 min read